ClinicalTrials.Veeva

Menu

Patient Preference for Biopsy Notification

M

Maria Wei

Status

Completed

Conditions

Elevated Risk for Melanoma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

Enrollment

301 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who were 18 years of age or older and English speaking were eligible to participate

Exclusion criteria

  • Younger than 18, non-English speaking.

Trial design

301 participants in 1 patient group

Elevated risk for melanoma
Description:
Individuals at increased risk for melanoma due to past history of melanoma, family history of melanoma, the presence of many moles, the presence of a genetic mutation known to increase the risk of melanoma.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems